REMD BIOTHERAPEUTICS
REMD Biotherapeutics employs biotechnology to develop new medication that aim to cure chronic illnesses such as metabolic disorders. It specializes in medical research, pharmaceutical services, and life sciences to help improve personal health. REMD Biotherapeutics has its headquarters in Camarillo in California, with branches throughout the United States and in China. It serves American and Chinese medical and pharmaceutical companies.
REMD BIOTHERAPEUTICS
Social Links:
Industry:
Alternative Medicine Biopharma Biotechnology Health Care Life Science Therapeutics
Founded:
2012-01-01
Address:
Camarillo, California, United States
Country:
United States
Website Url:
http://www.remdbio.com
Total Employee:
1+
Status:
Active
Contact:
(805) 987-0600
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apache Mobile Non Scaleable Content Google Maps Google Maps API Apple Mobile Web App Capable Apple Mobile Web App Status Bar Style Google Maps For Work
Current Employees Featured
Founder
Official Site Inspections
http://www.remdbio.com
- Host name: perfora.net
- IP address: 192.195.77.230
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "REMD Biotherapeutics"
REMD Biotherapeutics Inc
4010 Adolfo Rd., Suite A, Camarillo, CA 93012, United States (805) 987-0600See details»
REMD Biotherapeutics Company Profile 2024: …
Operator of a biopharmaceutical company intended to change the practice of medicine. The company develops protein therapeutics to treat cancer, diabetes, and other diseases, enabling patients to have access to effective, safe and …See details»
REMD Biotherapeutics - Crunchbase Company Profile …
REMD Biotherapeutics provides medications for chronic illnesses such as metabolic diseases. View contacts for REMD Biotherapeutics to access new leads and connect with decision-makers. REMD Biotherapeutics employs …See details»
REMD BIOTHERAPEUTICS INC. - LinkedIn
We, at REMD, are a biopharmaceutical company focused on discovering and developing cutting-edge bio-medicines to treat cancer, diabetes and other diseases.See details»
REMD Biotherapeutics Completes Enrollment and …
Jan 7, 2021 · REMD Bio completed enrollment and announced top-line results in a phase 2 clinical study of volagidemab (REMD-477) in patients with type 1 diabetes.See details»
REMD Biotherapeutics Inc
Since the founding of REMD Biotherapeutics the team has streamlined the entire process and have identified and characterized antibody candidates against multiple validated GPCR targets …See details»
REMD Biotherapeutics Announces Positive Top-Line
Jun 28, 2021 · REMD Biotherapeutics is a privately held, clinical-stage biotechnology company focused on creating and developing innovative protein-based therapies to treat metabolic diseases and other serious...See details»
REMD Biotherapeutics to Begin Phase 1B Clinical Study of REMD …
Dec 15, 2015 · REMD Biotherapeutics is a privately held, clinical-stage biotechnology company focused on creating and developing innovative protein-based therapies to treat metabolic …See details»
REMD Biotherapeutics Inc - REMD Biotherapeutics Inc
REMD Biotherapeutics Inc is a privately held clinical-stage biopharmaceutical company with R&D operations located in the US and China. The company was founded in Camarillo, CA in 2011 by two seasoned former Amgen research …See details»
REMD BIOTHERAPEUTICS PHASE 2 CLINICAL STUDY OF REMD …
Camarillo, CA - REMD Biotherapeutics, Inc. (“REMD Bio”), together with its subsidiary, Beijing-based Cosci-REMD Biotherapeutics (“Cosci-REMD Bio”), today announced that its phase 2 …See details»
REMD Biotherapeutics To Begin Phase 1B Clinical Study Of
Dec 15, 2015 · REMD Biotherapeutics is a privately held, clinical-stage biotechnology company focused on creating and developing innovative protein-based therapies to treat metabolic …See details»
REMD Biotherapeutics - Overview, News & Similar companies
View REMD Biotherapeutics (www.remdbio.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
REMD Biotherapeutics Phase II Clinical Study Of REMD-477 For
Nov 19, 2015 · REMD Biotherapeutics, Inc. (“REMD Bio”), together with its subsidiary, Beijing-based Cosci-REMD Biotherapeutics (“Cosci-REMD Bio”), today announced that its phase 2 …See details»
REMD Biotherapeutics Announces Positive Top-Line Results in
Jun 28, 2021 · REMD Biotherapeutics is a privately held, clinical-stage biotechnology company focused on creating and developing innovative protein-based therapies to treat metabolic …See details»
REMD BIOTHERAPEUTICS COMPLETES ENROLLMENT AND …
CAMARILLO, CA - REMD Biotherapeutics, Inc. (“REMD Bio”), together with its subsidiary, Beijing CoSci-REMD Bio Med-Tech Co, Ltd (“Cosci-REMD Bio”), today announced they have …See details»
REMD Biotherapeutics Completes Enrollment and Announces Top …
Jan 7, 2021 · REMD Biotherapeutics is a privately held, clinical-stage biotechnology company focused on creating and developing innovative protein-based therapies to treat metabolic …See details»
REMD Biotherapeutics Announces Dosing of First Type 1 Diabetes …
REMD Biotherapeutics, Inc., together with its subsidiary, Beijing CoSci-REMD Bio Med-Tech Co, Ltd (CoSci-REMD Bio), recently announced that the first patient with type 1 diabetes was …See details»
REMD Biotherapeutics Phase 2 Clinical Study of REMD-477 for …
Nov 19, 2015 · CAMARILLO, Calif.-- ( BUSINESS WIRE )-- REMD Biotherapeutics, Inc. (“REMD Bio”), together with its subsidiary, Beijing-based Cosci-REMD Biotherapeutics (“Cosci-REMD …See details»
News - REMD Biotherapeutics Inc
JOIN FORCES | GENSCRIPT BIOTECH & REMD BIOTHERAPEUTICS INC. REACHED A STRATEGIC COLLABORATION TO DEV.See details»
Hai Yan - Crunchbase Person Profile
Hai Yan is a reseacher on the discovery and early development of monoclonal antibodies and other protein therapeutics for cell surface receptors implicated in human metabolic diseases. …See details»